AMG 925 is a potent dual inhibitor of FLT3 and CDK4, selectively targeting key oncogenic pathways. It suppresses cancer cell proliferation and demonstrates significant antitumor activity in preclinical AML models, making it a promising candidate for targeted cancer therapy.
Usually ships within 24 hours.